Economic costs of diabetes in the U.S. in 2012 - Test2 - elhamkhani - TriplyDB

Economic costs of diabetes in the U.S. in 2012

Economic costs of diabetes in the U.S. in 2012

http://www.wikidata.org/entity/Q22241287

about

Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis The state of US health, 1990-2010: burden of diseases, injuries, and risk factors Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Mulberry therapy for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy Updates in diabetic peripheral neuropathy Cardiovascular Outcome Studies in Diabetes: How Do We Make Sense of These New Data?Patient considerations in type 2 diabetes - role of combination dapagliflozin-metformin XR Diabetes in migrants and ethnic minorities in a changing World Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives Yoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled Trials Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples Popular Glucose Tracking Apps and Use of mHealth by Latinos With Diabetes: Review Aloesin as a medical food ingredient for systemic oxidative stress of diabetes A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review The system of care for the diabetic foot: objectives, outcomes, and opportunities Infected animal models for tissue engineering Diabetic kidney disease: a report from an ADA Consensus Conference Guidelines for Perioperative Management of the Diabetic Patient Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples.Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 Analysis and valuation of the health and climate change cobenefits of dietary change Glucagon orchestrates stress-induced hyperglycaemia Current status of managing diabetes mellitus in Korea Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths?Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Current stem cell based therapies in diabetes Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy Dietary substitutions for refined carbohydrate that show promise for reducing risk of type 2 diabetes in men and women Inflammasomes and metabolic disorders: old genes in modern diseases Uncovering physiological mechanisms for health disparities in type 2 diabetes Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction Implications of supermarket access, neighbourhood walkability and poverty rates for diabetes risk in an employee population Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore

P2860

Q21146684-D8970527-6CB6-4325-BE4F-B9418C6DCDC9 Q23909354-C05CC926-1531-473E-BE55-7565200508C5 Q24186667-66D66EE5-F209-4E7C-B587-23401E700977 Q24188271-49DF6BD8-885C-4FAF-80F4-858CBCF31B65 Q24202505-E3B85773-2D68-4C77-8427-9ECDCC014FC5 Q24563917-A9FAF80D-C1DA-4875-87AE-3B77CCA6DB96 Q26748517-51CA86E7-F6CD-4CBE-A391-D313FF2F4D93 Q26751252-DFF3C6B1-23CD-4A08-80AF-E2A5EA466274 Q26752255-023F08BE-D2BB-43A3-AD1B-DF8F92013730 Q26766404-FE0DA72F-4BE2-4ECE-A299-36610BB39D97 Q26767102-FCFAB0BA-0952-4FDE-854C-D3A57F9B1CC8 Q26767263-96F660AC-B757-439D-8B8D-C9F73D83DE7B Q26770719-28CFF57E-D13D-407C-ADD6-8780E41D7304 Q26774170-5D24F320-2861-4B56-8916-91D43DA20419 Q26797368-E8DCC33A-CA2C-47D9-8703-51628AA69267 Q26798991-3D828144-FE6C-469C-ACB7-C41A0FE5C9BD Q26799686-BC58BF03-027B-4FFA-98D9-8D2D8AFF4F06 Q26822066-7B8A9834-395B-400D-9673-3A8B7D6AD92E Q26830274-63C56456-3510-41C3-9170-C922CAE9D378 Q26851806-F44388C0-7A17-4023-BDB1-D16C00D20EE6 Q26861462-E264BF51-EE79-4F51-8353-0A1391496EC9 Q27009020-735807C6-7FAF-4D82-94EC-138E7EA4793D Q27012546-98A918E5-4C02-4123-8EC1-E3B09B9AB7B8 Q27012832-2201B70D-A8B1-4341-B5BB-3713D606BA69 Q27318021-BB643355-DBB4-4BEE-B58B-382A204E191E Q27468570-D903A252-AB15-4556-8435-F675760595D3 Q28005515-60E4B709-9C3E-455E-9A20-30A22390DF03 Q28068879-15993FC7-4DCE-4117-8F48-E5EC384FB5C9 Q28069723-96469926-718F-453A-BAEC-EC4AB863B4D4 Q28069923-5F46EE28-E2F0-41E8-8395-49E01C19C725 Q28071012-2012752A-F914-4D24-99B7-5C0E0D53E20E Q28074914-B58C68A1-C24E-4BE9-872D-6E25DBDDB614 Q28077978-FC923ACB-7906-40FF-831B-D256EF45EAD6 Q28088331-D3F9CC4D-52CF-4DC9-9FB6-FDA05C40DFEB Q28254308-6F84B588-6FA8-48BC-8925-A73B9D622611 Q28389531-92A52599-2D1A-4A9E-B5AB-197793E11A34 Q28390809-7E4669E8-36F1-4370-B53A-FBCDF8A8EAEC Q28392149-AC502EB7-57A0-4C23-B137-3BAB74D6F2D3 Q28393660-F75E4078-2569-469B-8802-A3842EE47353 Q28542893-902A6845-3773-4939-BDBC-CBD1B5D6FF15

P2860

Economic costs of diabetes in the U.S. in 2012

http://www.wikidata.org/entity/Q22241287

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Economic costs of diabetes in the U.S. in 2012

@ast

Economic costs of diabetes in the U.S. in 2012

@en

Economic costs of diabetes in the U.S. in 2012

@en-gb

Economic costs of diabetes in the U.S. in 2012

@nl

type

label

Economic costs of diabetes in the U.S. in 2012

@ast

Economic costs of diabetes in the U.S. in 2012

@en

Economic costs of diabetes in the U.S. in 2012

@en-gb

Economic costs of diabetes in the U.S. in 2012

@nl

prefLabel

Economic costs of diabetes in the U.S. in 2012

@ast

Economic costs of diabetes in the U.S. in 2012

@en

Economic costs of diabetes in the U.S. in 2012

@en-gb

Economic costs of diabetes in the U.S. in 2012

@nl

P1433

Q22241287-556348A1-CE7A-4A3E-BBDD-3B9A798E5D07

P1476

Q22241287-AC270822-E41C-48B1-8751-CF8BA9C66859

P2860

Q22241287-0273B0FA-E3B3-4F49-9D8B-FC82B1D3BADF

Q22241287-08188F37-1B2C-4602-BF23-7CAEA2B811C7

Q22241287-1FBA2249-3E6C-4CF8-BAE1-5B19326B9885

Q22241287-2E379E51-3E93-44CC-808B-ABAC612FAE98

Q22241287-2E70FC45-2533-4811-8E30-B76CFEFF3096

Q22241287-2F9667E4-0D00-457B-9C37-EDB8CECC95B0

Q22241287-49046E99-4B7B-4D12-B915-A40B6ADF2FBD

Q22241287-4F9DF368-4B8B-4F2D-B4A9-B74B836FEEB4

Q22241287-54DFB798-5D19-489B-800C-908089C82844

Q22241287-591AF7A2-23ED-42B0-AF8A-66428EECEA3D

P304

Q22241287-AAD97FD0-5F72-449B-8310-56A6C50AE2BF

P31

Q22241287-A1BF5BEA-5D97-46B3-9305-8EF66F79096B

P3181

Q22241287-8EC89B36-161C-4C73-8C76-9BACC6254486

P356

Q22241287-B8C9B5FE-B1CB-4800-9731-6ECB4A73E80D

P407

Q22241287-553D9080-5A2D-4166-AEC4-E98D0404796B

P433

Q22241287-ED4204D0-1BCB-4DD6-9994-54166F053BCE

P478

Q22241287-3FD19707-0632-418A-8F8A-0C788DA12E58

P577

Q22241287-71948130-8572-4CCE-A4DF-EA394D8B16AC

P698

Q22241287-176796EF-6C68-4BF5-BB67-9D64EC519342

P932

Q22241287-4E24D2A6-3127-4292-882E-42AB0E0C14BB

P3181

P356

P1433

P1476

Economic costs of diabetes in the U.S. in 2012

@en

P2860

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

Impact of lifestyle intervention on lost productivity and disability: improving control with activity and nutrition

Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure.

Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data.

A review of adjusted estimators of attributable risk.

Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

The impact of diabetes on workforce participation: results from a national household sample.

Diabetes and coronary heart disease as risk factors for mortality in older adults.

Health spending projections through 2016: modest changes obscure part D's impact.

Economic costs of diabetes in the U.S. In 2007.

P304

1033-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

669767

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DC12-2625

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23468086

http://www.w3.org/2001/XMLSchema#string

P932

3609540

http://www.w3.org/2001/XMLSchema#string